Modular Medical, Inc.
MODDNasdaqCIK 1074871HealthcareFiscal year ends Mar 31
Reports and events: 181 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2816:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001213900-26-113310 |
| 2026-10-0109:24 ET | DEF 14A | Proxy statementPeriod 2026-10-23 | 0001213900-26-105495 |
| 2026-09-2916:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-26-104656 |
| 2026-09-0317:15 ET | 8-K | 5.08 Item not in the standard list | 0001213900-26-097280 |
| 2026-08-1417:25 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090301 |
| 2026-06-2917:24 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001213900-26-073223 |
| 2026-05-2016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-059557 |
| 2026-04-2112:20 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-045985 |
| 2026-04-1608:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-044343 |
| 2026-03-3116:35 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-037531 |
| 2026-03-1316:00 ET | 8-K | 8.01 Other events | 0001213900-26-027652 |
| 2026-03-0616:16 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-024671 |
| 2026-02-2711:38 ET | S-1 | Registration statement | 0001213900-26-021221 |
| 2026-02-2408:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-26-019603 |
| 2026-02-1716:00 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001213900-26-017262 |
| 2026-01-2317:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-007296 |
| 2026-01-0807:30 ET | DEF 14A | Proxy statementPeriod 2026-01-23 | 0001213900-26-002332 |
| 2025-12-3108:47 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-126825 |
| 2025-12-1117:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-120759 |
| 2025-11-1416:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-110819 |
| 2025-09-2308:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-090336 |
| 2025-08-1416:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-076594 |
| 2025-07-0217:00 ET | 8-K | 3.01 Delisting notice | 0001213900-25-061072 |
| 2025-06-2006:07 ET | 10-K | Annual reportPeriod 2025-03-31 | 0001213900-25-055793 |
| 2025-05-2816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-048276 |
| 2025-04-0718:20 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-25-002311 |
| 2025-03-2617:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001013762-25-002793 |
| 2025-03-2421:44 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000919574-25-002091 |
| 2025-03-0316:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-019397 |
| 2025-02-1316:00 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001213900-25-013462 |
| 2025-01-2417:29 ET | DEF 14A | Proxy statementPeriod 2025-02-28 | 0001213900-25-006614 |
| 2024-11-2716:55 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-09-30 | 0001213900-24-103547 |
| 2024-11-2519:18 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-24-006888 |
| 2024-11-2515:39 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-102121 |
| 2024-11-1416:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-098418 |
| 2024-09-0506:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-075772 |
| 2024-08-2716:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-072999 |
| 2024-08-1317:23 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068407 |
| 2024-06-2117:17 ET | 10-K | Annual reportPeriod 2024-03-31 | 0001213900-24-054877 |
| 2024-04-1017:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-031921 |
| 2024-02-2117:20 ET | SC 13D/A | Ownership report, active investor, amended | 0000919574-24-001617 |
| 2024-02-1617:27 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-014985 |
| 2024-02-1516:01 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-014542 |
| 2024-02-1316:40 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001213900-24-013348 |
| 2024-01-1908:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-004669 |
| 2024-01-0806:21 ET | DEF 14A | Proxy statementPeriod 2024-02-13 | 0001213900-24-001702 |
| 2023-12-2619:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-098330 |
| 2023-11-2217:26 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-23-089664 |
| 2023-11-1317:28 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-086248 |
| 2023-10-0516:29 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001013762-23-002171 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:11 ET. Listed shows no prices and gives no investment advice.